| Followers | 12 |
| Posts | 1963 |
| Boards Moderated | 0 |
| Alias Born | 04/16/2024 |
Saturday, October 26, 2024 10:41:04 AM
Recent SLDB News
- Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial • GlobeNewswire Inc. • 03/11/2026 05:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 09:36:43 PM
- Solid Biosciences Announces Oversubscribed $240 Million Private Placement • GlobeNewswire Inc. • 03/06/2026 01:31:00 PM
- Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference • GlobeNewswire Inc. • 03/06/2026 01:30:00 PM
- Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/02/2026 09:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/19/2026 02:35:21 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/19/2026 02:33:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:32:55 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/19/2026 02:32:35 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/19/2026 02:31:41 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:31:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:28:37 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/19/2026 02:28:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:25:06 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 09:08:21 PM
- Solid Biosciences Announces Positive Feedback from Type C Meeting with FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy • GlobeNewswire Inc. • 02/09/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 11:01:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 11:00:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:59:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:57:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2026 10:56:58 PM
- Solid Biosciences to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 • GlobeNewswire Inc. • 02/06/2026 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/05/2026 12:48:19 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/05/2026 12:46:07 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/05/2026 12:45:57 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
